#211 | The NUMBER ONE Reason Clinically Proven MedTech Products Still Fail
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Have you ever wondered why a clinically proven MedTech product can achieve regulatory approval, generate positive feedback, and still fail commercially?
Many clinician founders believe that strong clinical evidence is enough to drive adoption. Unfortunately, healthcare doesn't work that way. In this episode, Hakeem speaks with Holly Miller about why adoption is engineered long before launch and how behavioural science, market conditioning, and stakeholder alignment help transform innovative MedTech products from interesting ideas into the new standard of care.
Listeners will discover:
- Why clinical evidence alone rarely changes behaviour or guarantees adoption
- How to move your MedTech product from a "nice-to-have" to a "must-have" for the right audience
- The practical adoption strategies that successful MedTech companies use before launching into the market
Play this episode now to discover how to engineer adoption before launch and give your MedTech product the best chance of achieving commercial success and becoming the new standard of care.
Book a 30min Healthcare Export Accelerator discovery call
Message me via DM on Linkedin
This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.
Visit Holleys website for launch assessment belaunchready.com